SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the UZ Brussel Following COVID-19 Vaccination Using an Adenoviral Vector
Clinical trial NCT04939402 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04939402
- Sponsor
- Universitair Ziekenhuis Brussel
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-05
- Primary completion
- 2028-05-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.